S&P 500   5,083.48 (-0.10%)
DOW   39,127.38 (-0.01%)
QQQ   438.27 (+0.34%)
AAPL   180.84 (-0.92%)
MSFT   409.45 (-0.22%)
META   485.31 (+0.26%)
GOOGL   138.32 (-3.92%)
AMZN   175.02 (+0.02%)
TSLA   200.07 (+4.22%)
NVDA   801.46 (+1.69%)
NIO   5.57 (+3.15%)
AMD   176.65 (+0.07%)
BABA   76.20 (+0.32%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.24 (+6.09%)
CGC   3.45 (+2.68%)
GE   154.59 (+0.82%)
DIS   108.08 (+0.32%)
AMC   4.55 (+2.48%)
PFE   27.13 (-2.27%)
PYPL   59.54 (+0.64%)
XOM   104.30 (+0.44%)
S&P 500   5,083.48 (-0.10%)
DOW   39,127.38 (-0.01%)
QQQ   438.27 (+0.34%)
AAPL   180.84 (-0.92%)
MSFT   409.45 (-0.22%)
META   485.31 (+0.26%)
GOOGL   138.32 (-3.92%)
AMZN   175.02 (+0.02%)
TSLA   200.07 (+4.22%)
NVDA   801.46 (+1.69%)
NIO   5.57 (+3.15%)
AMD   176.65 (+0.07%)
BABA   76.20 (+0.32%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.24 (+6.09%)
CGC   3.45 (+2.68%)
GE   154.59 (+0.82%)
DIS   108.08 (+0.32%)
AMC   4.55 (+2.48%)
PFE   27.13 (-2.27%)
PYPL   59.54 (+0.64%)
XOM   104.30 (+0.44%)
S&P 500   5,083.48 (-0.10%)
DOW   39,127.38 (-0.01%)
QQQ   438.27 (+0.34%)
AAPL   180.84 (-0.92%)
MSFT   409.45 (-0.22%)
META   485.31 (+0.26%)
GOOGL   138.32 (-3.92%)
AMZN   175.02 (+0.02%)
TSLA   200.07 (+4.22%)
NVDA   801.46 (+1.69%)
NIO   5.57 (+3.15%)
AMD   176.65 (+0.07%)
BABA   76.20 (+0.32%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.24 (+6.09%)
CGC   3.45 (+2.68%)
GE   154.59 (+0.82%)
DIS   108.08 (+0.32%)
AMC   4.55 (+2.48%)
PFE   27.13 (-2.27%)
PYPL   59.54 (+0.64%)
XOM   104.30 (+0.44%)
S&P 500   5,083.48 (-0.10%)
DOW   39,127.38 (-0.01%)
QQQ   438.27 (+0.34%)
AAPL   180.84 (-0.92%)
MSFT   409.45 (-0.22%)
META   485.31 (+0.26%)
GOOGL   138.32 (-3.92%)
AMZN   175.02 (+0.02%)
TSLA   200.07 (+4.22%)
NVDA   801.46 (+1.69%)
NIO   5.57 (+3.15%)
AMD   176.65 (+0.07%)
BABA   76.20 (+0.32%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.24 (+6.09%)
CGC   3.45 (+2.68%)
GE   154.59 (+0.82%)
DIS   108.08 (+0.32%)
AMC   4.55 (+2.48%)
PFE   27.13 (-2.27%)
PYPL   59.54 (+0.64%)
XOM   104.30 (+0.44%)

Aptevo Therapeutics (APVO) SEC Filings & 10K Form

$0.14
+0.01 (+6.74%)
(As of 12:39 PM ET)

Recent Aptevo Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2024
2:24 PM
Aptevo Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
02/06/2024
3:37 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
5:02 PM
Aptevo Therapeutics (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:04 PM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:05 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:00 AM
Aptevo Therapeutics (Filer)
Form DEFR14A
12/12/2023
3:19 PM
Aptevo Therapeutics (Filer)
Form PRE 14A
11/30/2023
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
11/09/2023
4:17 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
3:30 PM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:41 AM
Aptevo Therapeutics (Issuer)
Lamothe Jeffrey G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:44 AM
Aptevo Therapeutics (Issuer)
Kwon SoYoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:47 AM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:16 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
7:30 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
11:15 PM
Aptevo Therapeutics (Filer)
Form EFFECT
08/01/2023
3:01 PM
Aptevo Therapeutics (Filer)
Form S-1/A
07/18/2023
7:16 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
3:16 PM
Aptevo Therapeutics (Filer)
Form S-1/A
06/30/2023
3:16 PM
Aptevo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/11/2023
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
7:31 AM
Aptevo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/19/2023
7:31 AM
Aptevo Therapeutics (Filer)
Form DEFA14A
04/18/2023
7:33 AM
Aptevo Therapeutics (Filer)
Form ARS
04/18/2023
7:30 AM
Aptevo Therapeutics (Filer)
Form DEF 14A
03/30/2023
7:01 AM
Aptevo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/30/2023
6:50 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2023
6:40 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2023
3:30 PM
Aptevo Therapeutics (Issuer)
Taylor Daphne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2023
7:15 AM
Aptevo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:APVO) was last updated on 2/26/2024 by MarketBeat.com Staff